Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Adalimumab in Subjects With Chronic Plaque Psoriasis and Nail Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the safety and efficacy of adalimumab in subjects with chronic plaque psoriasis and nail psoriasis. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nail Psoriasis
• Plaque Psoriasis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: AbbVie | Conditions: Nail Psoriasis, Plaque Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2017-02-13